Skip to main content
M

MEDICALSYSTEM BIOTECHNOLOGY CO., LTD — Investor Relations & Filings

Ticker · 300439 LEI · 3003007XTAWFVR8ASC23 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,709 across all filing types
Latest filing 2026-03-13 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300439

About MEDICALSYSTEM BIOTECHNOLOGY CO., LTD

https://www.nbmksw.com

MedicalSystem Biotechnology Co., Ltd. specializes in the research, development, production, and distribution of in vitro diagnostic (IVD) products. The company offers a comprehensive portfolio that includes biochemical reagents, chemiluminescence immunoassay systems, molecular diagnostic kits, and point-of-care testing (POCT) solutions. Its product line covers a wide range of clinical applications such as liver function, kidney function, blood lipids, and cardiovascular markers. MedicalSystem is recognized for its integrated business model, which combines the manufacturing of high-quality diagnostic instruments with a vast array of compatible reagents. Additionally, the company provides third-party medical laboratory services to healthcare institutions. By focusing on technological innovation and standardized production, MedicalSystem supports clinical laboratories in achieving accurate and efficient diagnostic results for improved patient care.

Recent filings

Filing Released Lang Actions
关于公司取得医疗器械注册证的公告
Regulatory Filings
2026-03-13 Chinese
关于公司及控股子公司取得医疗器械注册证的公告
Regulatory Filings
2026-02-24 Chinese
关于使用部分闲置募集资金进行现金管理的进展公告
Regulatory Filings
2026-02-06 Chinese
关于公司及控股子公司取得医疗器械注册证的公告
Regulatory Filings
2026-01-30 Chinese
2025年度业绩预告
Regulatory Filings
2026-01-30 Chinese
关于公司取得医疗器械注册证的公告
Regulatory Filings
2026-01-09 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.